DeepQure
PrivateLast Round
Series C
Apr 28, 2025
Company Overview
DeepQure is a medical device company that develops extravascular renal denervation systems for the treatment of resistant hypertension and other cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepQure Comparables
Compare DeepQure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ablative Solutions | 81% | |
| Otsuka Holdings | 80% | |
| Cortex, Inc. | 79% |
DeepQure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 28, 2025 |
DeepQure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sui Generis Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
Jason G. Jones appointed as Global Vice President of Clinical & Regulatory Affairs.
- Jun 1, 2025
Monthly visitors grew 118% MoM.
DeepQure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DeepQure's valuation, stock price, and market status.
Is DeepQure a public or private company?
DeepQure is a private company.
What is the current stock price of DeepQure?
DeepQure is a private company with no public stock price. No recent secondary market data is available.
How much is DeepQure worth (valuation)?
Valuation information for DeepQure is not publicly available.
Can I buy DeepQure stock?
DeepQure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DeepQure's last funding round?
DeepQure's most recent funding round was Series C on April 28, 2025.
Who are the main investors in DeepQure?
Key investors in DeepQure include Sui Generis Partners.
Will DeepQure IPO soon?
No public IPO plans have been announced for DeepQure.
How can I track DeepQure secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeepQure's secondary market activity and sign up for updates.